Anti-BRD3 抗体 [EPR23743-226] (ab300106)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR23743-226] to BRD3
- Suitable for: WB
- Knockout validated
- Reacts with: Human
Related conjugates and formulations
製品の概要
-
製品名
Anti-BRD3 antibody [EPR23743-226]
BRD3 一次抗体 製品一覧 -
製品の詳細
Rabbit monoclonal [EPR23743-226] to BRD3 -
由来種
Rabbit -
アプリケーション
適用あり: WBmore details
適用なし: ChIP,Flow Cyt (Intra),ICC/IF,IHC-P or IP -
種交差性
交差種: Human
非交差種: Mouse -
免疫原
Recombinant fragment. This information is proprietary to Abcam and/or its suppliers.
-
ポジティブ・コントロール
- WB: Wild type HEK-293T (human embryonic kidney epithelial cell), whole cell lysate, HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate.
-
特記事項
Ab300106 is not reactive in ICC and Flow Cyt. with Mouse and Rat species.
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
バッファー
pH: 7.2
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA -
Concentration information loading...
-
精製度
Protein A purified -
ポリ/モノ
モノクローナル -
クローン名
EPR23743-226 -
アイソタイプ
IgG -
研究分野
関連製品
-
Alternative Versions
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab300106の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
WB |
1/1000. Detects a band of approximately 100 kDa (predicted molecular weight: 80 kDa).
|
特記事項 |
---|
WB
1/1000. Detects a band of approximately 100 kDa (predicted molecular weight: 80 kDa). |
ターゲット情報
-
組織特異性
Ubiquitous. -
関連疾患
Note=A chromosomal aberration involving BRD3 is found in a rare, aggressive, and lethal carcinoma arising in midline organs of young people. Translocation t(15;9)(q14;q34) with NUT which produces a BRD3-NUT fusion protein. -
配列類似性
Contains 2 bromo domains. -
細胞内局在
Nucleus. - Information by UniProt
-
参照データベース
- Entrez Gene: 8019 Human
- Omim: 601541 Human
- SwissProt: Q15059 Human
- Unigene: 522472 Human
- Unigene: 654869 Human
-
別名
- BRD 3 antibody
- Brd3 antibody
- BRD3_HUMAN antibody
see all
画像
-
All lanes : Anti-BRD3 antibody [EPR23743-226] (ab300106) at 1/1000 dilution
Lane 1 : Wild type HEK-293T (human embryonic kidney epithelial cell), whole cell lysate
Lane 2 : BRD3 knockout HEK-293T whole cell lysate
Lane 3 : HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate
Lysates/proteins at 20 µg per lane.
Secondary
All lanes : Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) at 1/10000 dilution
Predicted band size: 80 kDa
Observed band size: 100 kDa why is the actual band size different from the predicted?Blocking and dilution buffer and concentration: Intercept® (TBS) Blocking Buffer diluted with an equal volume of 0.1% TBS.
The identity of the lower MW band at approximately 50kDa is unknown.
Lysates/proteins at 20 µg per lane.
Performed under reducing conditions.
False colour image of Western blot: Anti-BRD3 antibody [EPR23743-226] staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody 6C5 loading control staining at 1/20000 dilution, shown in red.
In Western blot, ab300106 was shown to bind specifically to BRD3. A band was observed at 100 kDa in wild-type HEK-293 cell lysates with no signal observed at this size in BRD3 knockout cell line ab266793 (knockout cell lysate ab258335). To generate this image, wild-type and BRD3 knockout HEK-293 cell lysates were analyzed. First, samples were run on an SDS-PAGE gel then transferred onto an immobilon-FL PVDF membrane. Membranes were blocked in Intercept® (TBS) Blocking Buffer diluted with an equal volume of 0.1% TBS before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/10000 dilution.
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
SDS download
-
Datasheet download
Certificate of Compliance
参考文献 (0)
ab300106 は論文での使用が確認できていません。